Search results
Results from the WOW.Com Content Network
A closely related condition is multifocal serpiginoid choroiditis. This is caused by tuberculosis. [3] The distinction between these two conditions is important as the latter responds to anti tuberculosis treatment while the former does not. Choroidal neovascularization (CNV) is the most common complication associated with Serpiginous choroiditis.
During the COVID-19 pandemic, raw VAERS data has often been disseminated by anti-vaccine groups in order to justify inaccurate safety claims related to COVID-19 vaccines, including adverse reactions and alleged fatalities claimed to have been caused by vaccines.
It may cause some mild side effects, such as pain in your arm, and he suggests planning to rest for a day or two after the shot. ... CDC. Use of COVID-19 Vaccines for Persons Aged ≥6 Months: ...
Some claimed vaccine injuries are not, in fact, caused by vaccines; for example, there is a subculture of advocates who attribute their children's autism to vaccine injury, [7] despite the fact that vaccines do not cause autism. [8] [9] Claims of vaccine injuries appeared in litigation in the United States in the latter part of the 20th century.
The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be reasonably well-matched,” he says.
Unlike multiple evanescent white dot syndrome, multifocal choroiditis is a chronic disorder and macular scarring contributes to severe visual loss. Theories regarding the cause include an exogenous pathogen sensitizing an individual to antigens within photoreceptors, retinal pigment epithelium, or choroid. [2] [6]
To identify a two-fold risk of a vaccine-associated adverse event that occurs in once in 100,000 people, 2.35 million people who have received the vaccine need to be compared with 2.35 million ...
Vaccine-associated enhanced respiratory disease (VAERD), or simply enhanced respiratory disease (ERD), is an adverse event where an exacerbated course of respiratory disease occurs with higher incidence in the vaccinated population than in the control group. It is a barrier against vaccine development that can lead to its failure.